Personalised medicine is a field in which physicians perform tests to identify specific drugs and interventions suitable to an individual patient.
Nanomedicine and personalised diagnostic medicine will be one of the fundamental challenges for the next decades.
The Biomedical Informatics Group is a pioneer in this field linking genomic and clinical information. Advances based on the Human Genome Project and the development of high-throughput techniques have led to personalized medicine opportunities such as personalized diagnoses, therapies and drugs, revolutionizing therapeutic procedures and health care.
We participate in the EC project P-medicine which has brought together leading research groups in Europe to design and implement technological solutions. Its goals involve sharing large-scale datasets in a secure fashion, performing Virtual Physiological Human simulations and running complex data workflows involving statistical analysis and Data Mining. Several test-scenarios evaluate clinical trials on cancer —Wilms tumor, breast cancer and leukaemia trials.
In p-medicine 19 partners from 9 European countries and Japan have dedicated themselves to create support and sustain new knowledge and technologies to overcome current problems in clinical research. More...
The main purpose of “Tratamiento 2.0” is to create a generic middleware platform using Ambient Intelligence, ubiquitous computing, expert systems and AI, Augmented Reality, Human Machine Interfaces, etc. More...
The main objective of the project is the creation of centres of excellence to promote health research, education and practice in Africa. The creation of these centres will be based on four main pillars: e-learning, knowledge sharing, "know-how" and information technologies. More...